Department of Pathology Microbiology and Immunology

March 28, 2024

Study identifies molecule as potential target for treating AML

While immune checkpoint inhibitors that target the PD-1 molecule on T-cells have proven to be effective with many cancers, these immunotherapies have not worked for acute myeloid leukemia (AML), but new research has identified a “cousin” molecule as a potential therapeutic target for AML. 

By Tom Wilemon
March 18, 2024

VUMC’s Jay Jerome honored by Microscopy Society of America

Jerome is the 2024 recipient of the Distinguished Scientist Award, which honors “preeminent senior scientists for a long-standing record of achievement in the field of microscopy and microanalysis.”

By Bill Snyder
March 5, 2024

New Vanderbilt Medical Laboratories facility, renovations will benefit patients

A new Vanderbilt University Medical Center clinical laboratory facility is open for business following a relocation to a 110,000 square-foot facility in MetroCenter. The new lab is located approximately five miles from VUMC’s main Nashville campus.

By Jill Clendening
February 16, 2024

Waddell Walker Hancock Cancer Discovery Fund names first scholars

A research endeavor that seeks to develop a new cancer immunotherapy utilizing nanobody delivery and targeted heating of tumors has received funding from the Waddell Walker Hancock Cancer Discovery Fund.

By Tom Wilemon
February 1, 2024

Romney Humphries receives John V. Bergen Excellence Award

Vanderbilt’s Romney Humphries, PhD, has received the 2024 John V. Bergen Excellence Award from the Clinical and Laboratory Standards Institute.

By Leigh MacMillan
January 16, 2024

‘Molecular Muse’ exhibit features Artist-in-Residence program’s science-inspired art

The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool.

By Leigh MacMillan
January 11, 2024

VUMC’s James Nichols to lead lab standards institute

James Nichols, PhD, medical director of Clinical Chemistry and Point-of-Care Testing at Vanderbilt University Medical Center, has begun a two-year term as president of the Clinical and Laboratory Standards Institute.
By Bill Snyder
December 29, 2023

Glucose metabolism influences B cell function

Glucose metabolism influences the qualities of activated, mature B cells — white blood cells that are required for antibody-mediated immune responses, Vanderbilt researchers discovered.
By Leigh MacMillan
December 8, 2023

Gut microbiota metabolite protects against obesity: study

Vanderbilt researchers have discovered that beneficial bacteria in the small intestines produce a compound that protects against obesity.
By Leigh MacMillan
December 6, 2023

Pasteurization reduces bioactive component of breast milk

Pasteurization of breast milk affects the concentration of osteopontin, a bioactive protein with roles in intestinal, immunological and brain development — suggesting that osteopontin supplementation should be considered when donor milk is provided to preterm infants.
By Leigh MacMillan
November 22, 2023

Lab transformation project underway; will modernize clinical lab operations

By VUMC News and Communications
November 21, 2023

Commensal gut bacterium protects from severe intestinal infection

The commensal bacterium Turicibacter sanguinis could be used to protect against severe intestinal infections, Vanderbilt researchers discovered.
By Leigh MacMillan
November 17, 2023

Tumor antigens key to improving cancer immunotherapy: study

Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients.
By Bill Snyder
1 2 3 4 … 30